Taken together, the BNIP3/Nix pathway provides a novel idea to ameliorate mitochondrial damage and reduce fibrosis in renal tubular cells, providing a potential target for the treatment and prevention of CKD. This evidence concerns the gene BNIP3L and chronic kidney disease.